Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
10 studies found for:    Open Studies | "Coccidioidomycosis"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Coccidioidomycosis"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Not yet recruiting Sertraline in Addition to Standard of Care Treatment for Coccidioidomycosis
Condition: Coccidioidomycosis
Intervention: Drug: Sertraline
2 Recruiting Early Fluconazole Treatment for Coccidiodomycosis Pneumonia
Condition: Coccidioidomycosis
Interventions: Other: Placebo;   Drug: Fluconazole
3 Recruiting Pathogenesis and Genetics of Disseminated or Refractory Coccidioidomycosis
Condition: Coccidioidomycosis
4 Recruiting Parasitic Infections of the Gastrointestinal Tract
Conditions: Amebiasis;   Cryptosporidiosis;   Giardiasis;   Parasitic Disease;   Parasitic Intestinal Disease;   Gastrointestinal Helminth Infections
5 Recruiting Lyon Cohort of Maternal and Congenital Toxoplasma Infections
Condition: Toxoplasmosis, Congenital
6 Not yet recruiting Determination of Genetic Susceptibility in Severe Recurrences of Ocular Toxoplasmosis
Conditions: Toxoplasmosis Infection;   Genotype II;   Ocular Toxoplasmosis With Recurrences
Intervention: Biological: seropositive for Toxoplasma gondii
7 Recruiting Cryptosporidiosis and Enteropathogens in Bangladesh
Condition: Cryptosporidiosis
8 Unknown  Trial of Ceramic Water Filters to Reduce Cryptosporidium Infection in Kenya
Conditions: Cryptosporidium;   Cryptosporidiosis;   Waterborne Disease;   Diarrheal Disease
Intervention: Other: Ceramic water filter
9 Unknown  Assessment of Two Therapeutic Strategies in the Treatment of Children With Congenital Toxoplasmosis
Condition: Congenital Toxoplasmosis
Interventions: Procedure: reducing treatment to 3 months;   Procedure: registered length of treatment
10 Recruiting Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
Condition: Toxoplasmosis
Interventions: Drug: Leucovorin calcium;   Drug: Pyrimethamine;   Drug: Spiramycin;   Drug: Sulfadiazine

Indicates status has not been verified in more than two years